ReviewJournal of current glaucoma practice
Clinical Complications and Comorbidities Associated with Secondary Glaucoma: A Structured Literature Review.
Review in Journal of current glaucoma practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Secondary glaucoma is caused by underlying medical conditions, ocular injury, or drugs that increase intraocular pressure (IOP), causing damage to the optic nerve. It has a multifactorial etiology, making diagnosis and treatment complicated, and posing risks of irreversible loss of vision or blindness if left untreated. Aim: The review assessed clinical complications and comorbidities of secondary glaucoma. Materials and methods: A literature review was conducted using PubMed, Scopus, and Google Scholar, focusing on studies from the past decade. Included studies involved patients aged ≥40 years diagnosed with secondary glaucoma in tertiary care or ophthalmology centers. Data on clinical complications, surgical outcomes, visual impacts, and the influence of hypertension, diabetes, and treatment modalities were analyzed. Results: Patients with secondary glaucoma were found to have a significantly higher incidence of comorbidities such as hypertension and diabetes. Pseudoexfoliation syndrome was described as the most common secondary glaucoma. The visual acuity test results were variable for a given patients, and the mean IOP for neovascular glaucoma stood at 40.67 mm Hg. Cup-to-disk ratio varied for traumatic and uveitic glaucoma, indicating structural damage to the optic nerve. The male patients had higher prevalence rates. Conclusion: Early diagnosis and a multidisciplinary management strategy are essential for preventing complications of secondary glaucoma. Modern diagnostic modalities such as optical coherence tomography and visual field testing, along with targeted therapies, can improve clinical outcomes and minimize morbidity. Contribution: This review provides an overview of the complications associated with secondary glaucoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.